Dr. Jose G. Bazan
Claim this profileOhio State University Comprehensive Cancer Center
Studies Breast Cancer
Studies Breast cancer
7 reported clinical trials
15 drugs studied
Area of expertise
1Breast Cancer
Stage IV
ER positive
Stage I
2Breast Cancer
Stage IV
ER positive
Stage II
Affiliated Hospitals
Clinical Trials Jose G. Bazan is currently running
SBRT and Imaging
for Metastatic Breast Cancer
This phase II trial tests how well stereotactic body radiation therapy (SBRT) works in treating patients with estrogen receptor positive (ER +) breast cancer that has spread from where it first started to other places in the body (metastatic) and has limited disease progression (oligoprogression). Currently, the standard of care for breast cancer patients with oligoprogressive disease is to change systemic therapy when progression occurs. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. SBRT is a type of external radiation therapy that uses special equipment to position a patient and precisely deliver radiation to tumors in the body (except the brain). The total dose of radiation is divided into smaller doses (fractions) given over several days. This type of radiation therapy helps spare normal tissue and has been shown to improve survival. SBRT may kill more tumor cells and allow patients with oligoprogressive ER + metastatic breast cancer to continue taking current systemic treatment. This trial also tests how well ER targeted positron emission tomography (PET)/ computed tomography (CT) imaging, using FES, works in identifying progressive disease in patients with ER + metastatic breast cancer. FES, a radiolabeled substance, binds to estrogen receptors and gives off radiation that can be detected by a PET scan. The PET scan, an established imaging technique that utilizes small amounts of radioactivity attached to very minimal amounts of tracer, FES, forms an image that shows where tumor cells with estrogen receptors can be found in the body. CT images use x-rays to provide an exact outline of organs. FES PET/CT may improve identification of progressive disease in patients with ER + metastatic breast cancer.
Recruiting1 award Phase 2
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
More about Jose G. Bazan
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Jose G. Bazan has experience with
- F-18 16 Alpha-Fluoroestradiol
- Stereotactic Body Radiation Therapy
- Berzosertib
- Radiation Therapy
- Docetaxel
- Erlotinib Hydrochloride
Breakdown of trials Jose G. Bazan has run
Breast Cancer
Breast cancer
Skin Cancer
Thyroid Cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jose G. Bazan specialize in?
Jose G. Bazan focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are ER positive.
Is Jose G. Bazan currently recruiting for clinical trials?
Yes, Jose G. Bazan is currently recruiting for 2 clinical trials in Columbus Ohio. If you're interested in participating, you should apply.
Are there any treatments that Jose G. Bazan has studied deeply?
Yes, Jose G. Bazan has studied treatments such as F-18 16 Alpha-Fluoroestradiol, Stereotactic Body Radiation Therapy, Berzosertib.
What is the best way to schedule an appointment with Jose G. Bazan?
Apply for one of the trials that Jose G. Bazan is conducting.
What is the office address of Jose G. Bazan?
The office of Jose G. Bazan is located at: Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210 United States. This is the address for their practice at the Ohio State University Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.